Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-12-13FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
FDA approved Mayne Pharma's supplemental application for isotretinoin.
-
CLINICAL_TRIALS research · 2014-12-11Clinical Trial Update: Psychological Factors in Acne: A Focus on Psychological Trauma
This is a clinical trial update from Edinburgh Napier University studying psychological factors in acne with a focus on psychological trauma…
-
FDA approval · 2014-12-05FDA Approved: BENZAMYCIN — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for Benzamycin (erythromycin and benzoyl peroxide) by Bausch Health US, LLC.
-
CLINICAL_TRIALS withdrawal · 2014-12-04Clinical Trial Update: Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris [NA]
A clinical trial comparing topical 5-ALA-PDT with Blu-U therapy to topical 5-ALA with pulse dye laser for recalcitrant acne vulgaris has bee…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris [Phase 3]
Phase 3 trial comparing Duac (benzoyl peroxide/clindamycin) with clindamycin phosphate gel in mild-to-moderate acne vulgaris; results have b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-11-24FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ACANYA (clindamycin phosphate and benzoyl peroxide) from Bausch Health US, LLC. The action adds …
-
FDA approval · 2014-10-27FDA Approved: ADAPALENE — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma’s original ANDA for adapalene, a generic topical retinoid used for acne.
-
FDA approval · 2014-10-21FDA Approved: MINOCYCLINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for minocycline hydrochloride (ANDA) from Chartwell RX, LLC.
-
FDA approval · 2014-10-20FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA (isotretinoin) from Sun Pharmaceutical Industries, Inc., enabling changes to the pr…
-
FDA approval · 2014-09-12FDA Approved: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for clindamycin phosphate and benzoyl peroxide (generic BenzaClin) by Mylan Pharmaceuticals Inc., fo…
-
FDA approval · 2014-08-21FDA Approved: RETIN-A MICRO — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for RETIN-A MICRO (tretinoin) from Bausch Health US LLC.
-
FDA approval · 2014-08-15FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA (isotretinoin) submitted by Sun Pharmaceutical Industries, Inc. The approval update…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects [Phase 3]
This is a Phase 3 confirmatory trial (STF115288) of GI148512 for acne vulgaris in Japanese subjects; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Comparison of Efficacy Between Fractional Microneedling Radiofrequency and Bipolar Radiofrequency for Acne Scar [NA]
This completed trial compares fractional microneedling radiofrequency versus bipolar radiofrequency for the treatment of acne scars to evalu…
-
FDA label_change · 2014-08-01FDA Approved: EPIDUO — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for EPIDUO (adapalene and benzoyl peroxide) from Galderma Laboratories, L.P., likely affecting the p…
-
FDA approval · 2014-07-30FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ABSORICA (isotretinoin) submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2014-07-01FDA Approved: EPIDUO — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for Epiduo (adapalene and benzoyl peroxide) by Galderma Laboratories, L.P., updating its labeling.
-
FDA approval · 2014-06-13FDA Approved: ADAPALENE — Supplemental Application (Mayne Pharma Commercial LLC.)
FDA approved a supplemental application for adapalene submitted by Mayne Pharma Commercial LLC.
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Clinical Trial of Lupeol for Mild-moderate Acne [NA]
The document notes the completion of a clinical trial evaluating Lupeol for mild to moderate acne.
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients [Phase 2]
Phase 2 trial evaluating photoactive porphyrin (PAP) levels after topical application of Visonac in acne patients; results were posted in 20…
-
CLINICAL_TRIALS withdrawal · 2014-05-13Clinical Trial Update: Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris [Phase 2]
A Phase 2 study evaluating safety, tolerability, and effects of PF-05175157 in adults with moderate to severe acne vulgaris has been withdra…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of dapsone in acne vulgaris completed with results posted in 2014.
-
FDA label_change · 2014-03-18FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for ACANYA (clindamycin phosphate and benzoyl peroxide) from Bausch Health US, LLC, resulting in…
-
FDA approval · 2014-03-05FDA Approved: DOXYCYCLINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' generic doxycycline (DOXYCYCLINE) under an original application.
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris [Phase 2]
Phase 2 trial evaluating gevokizumab for moderate-to-severe acne vulgaris has completed; the update covers efficacy and safety findings.